Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 15 articles:
HTML format
Text format



Single Articles


    July 2017
  1. VIOLI F, Targher G, Vestri A, Carnevale R, et al
    Effect of aspirin on renal disease progression in patients with type 2 diabetes: A multicenter, double-blind, placebo-controlled, randomized trial. The renaL disEase progression by aspirin in diabetic pAtients (LEDA) trial. Rationale and study design.
    Am Heart J. 2017;189:120-127.
    PubMed     Text format     Abstract available


    June 2017
  2. DALBY AJ, Gottlieb S, Cyr DD, Magnus Ohman E, et al
    Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.
    Am Heart J. 2017;188:156-166.
    PubMed     Text format     Abstract available


    May 2017
  3. DEEDWANIA P, Acharya T, Kotak K, Fonarow GC, et al
    Compliance with guideline-directed therapy in diabetic patients admitted with acute coronary syndrome: Findings from the American Heart Association's Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program.
    Am Heart J. 2017;187:78-87.
    PubMed     Text format     Abstract available


  4. MENTZ RJ, Bethel MA, Gustavson S, Thompson VP, et al
    Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
    Am Heart J. 2017;187:1-9.
    PubMed     Text format     Abstract available


    March 2017
  5. NAKANISHI K, Jin Z, Homma S, Elkind MS, et al
    Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions (CABL) study.
    Am Heart J. 2017;185:85-92.
    PubMed     Text format     Abstract available


  6. CHAMBERLAIN AM, Alonso A, Gersh BJ, Manemann SM, et al
    Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Am Heart J. 2017;185:74-84.
    PubMed     Text format     Abstract available


  7. KUPSKY DF, Ahmed AM, Sakr S, Qureshi WT, et al
    Cardiorespiratory fitness and incident heart failure: The Henry Ford ExercIse Testing (FIT) Project.
    Am Heart J. 2017;185:35-42.
    PubMed     Text format     Abstract available


  8. KHETAN A, Purushothaman R, Zullo M, Gupta R, et al
    Rationale and design of a cluster-randomized controlled trial to evaluate the effects of a community health worker-based program for cardiovascular risk factor control in India.
    Am Heart J. 2017;185:161-172.
    PubMed     Text format     Abstract available


    February 2017
  9. NEWMAN JD, Rockman CB, Kosiborod M, Guo Y, et al
    Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease.
    Am Heart J. 2017;184:114-120.
    PubMed     Text format     Abstract available


    December 2016
  10. ECHOUFFO-TCHEUGUI JB, Xu H, DeVore AD, Schulte PJ, et al
    Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry.
    Am Heart J. 2016;182:9-20.
    PubMed     Text format     Abstract available


  11. GRODZINSKY A, Arnold SV, Wang TY, Sharma P, et al
    Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy.
    Am Heart J. 2016;182:111-118.
    PubMed     Text format     Abstract available


    November 2016
  12. VIRANI SS, Akeroyd JM, Ramsey DJ, Chan WJ, et al
    Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act.
    Am Heart J. 2016;181:74-82.
    PubMed     Text format     Abstract available


  13. MONDESIR FL, Brown TM, Muntner P, Durant RW, et al
    Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS).
    Am Heart J. 2016;181:43-51.
    PubMed     Text format     Abstract available


    September 2016
  14. MARSO SP, McGuire DK, Zinman B, Poulter NR, et al
    Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.
    Am Heart J. 2016;179:175-83.
    PubMed     Text format     Abstract available


    May 2016
  15. SHIMADA YJ, Cannon CP, Liu Y, Wilson C, et al
    Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care
    Am Heart J. 2016;175:18-27.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: